Globus Medical, Inc. (GMED)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Globus Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Globus Medical, Inc. (GMED) has returned -1.32% so far this year and 17.70% over the past 12 months. Looking at the last ten years, GMED has achieved an annualized return of 13.73%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Aug 3, 2012, GMED's average daily return is +0.08%, while the average monthly return is +1.64%. At this rate, your investment would double in approximately 3.6 years.

Historically, 59% of months were positive and 41% were negative. The best month was Nov 2025 with a return of +50.8%, while the worst month was Feb 2023 at -22.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 6 months.

On a daily basis, GMED closed higher 51% of trading days. The best single day was Nov 7, 2025 with a return of +35.9%, while the worst single day was May 9, 2025 at -23.0%.

Globus Medical, Inc. has an annualized alpha of 8.64%, beta of 0.90, and R² of 0.19 versus S&P 500 Index. Calculated based on daily prices since August 06, 2012.

• This stock captured 120.51% of S&P 500 Index gains and 110.86% of its losses — amplifying both gains and losses, but participating more in upside than downside.
• R² of 0.19 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GMED ranks 54 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.

The table below present risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Globus Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Globus Medical, Inc. was 47.91%, occurring on Nov 13, 2023. Recovery took 258 trading sessions.

The current Globus Medical, Inc. drawdown is 10.91%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Globus Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Globus Medical, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.